Awakn Life Sciences Reports Results for Quarter Ended April 30, 2022
Awakn delivered revenue growth of 24% in the quarter TORONTO, CANADA, June 14, 2022 – Awakn Life Sciences Corp. (NEO: AWKN, OTCQB: AWKNF, FSE: 954) (‘Awakn’), a biotechnology company, researching, developing,…